Cargando…
Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
BACKGROUND: Malignant urachal tumor is a rare subtype of genitourinary cancer. Our aim was to explore the optimal chemotherapy regimens for relapsed or metastatic urachal carcinoma. MATERIALS AND METHODS: We retrospectively enrolled 24 adult patients with relapsed or metastatic urachal carcinoma fro...
Autores principales: | Chen, Meiting, Xue, Cong, Huang, Ri-qing, Ni, Meng-qian, Li, Lu, Li, Hai-feng, Yang, Wei, Hu, An-qi, Zheng, Zhou-san, An, Xin, Shi, Yanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479186/ https://www.ncbi.nlm.nih.gov/pubmed/34604084 http://dx.doi.org/10.3389/fonc.2021.739134 |
Ejemplares similares
-
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
por: Szarvas, Tibor, et al.
Publicado: (2022) -
Clinical and Radiological Features of Urachal Carcinoma and Infection
por: Li, Shichao, et al.
Publicado: (2021) -
Urachal adenocarcinoma surgical management – Emphasis on enbloc umbilectomy and urachal remnant excision with negative margins
por: Althaf, Syed, et al.
Publicado: (2019) -
Metastatic Urachal Carcinoma Treated With Several Different Combined Regimens: A Case Report
por: Zheng, Han, et al.
Publicado: (2021) -
A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab
por: Kanamaru, Tomohiro, et al.
Publicado: (2014)